You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 14, 2025

Details for Patent: 11,202,778


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,202,778 protect, and when does it expire?

Patent 11,202,778 protects PHYRAGO and is included in one NDA.

This patent has six patent family members in six countries.

Summary for Patent: 11,202,778
Title:Amorphous solid dispersions of dasatinib and uses thereof
Abstract:Amorphous solid dispersions and pharmaceutical compositions of the protein kinase inhibitor dasatinib. The pharmaceutical compositions may be used in methods of treating a proliferative disorder such as cancer, or in methods of delivering dasatinib to patients without regard to whether the patient is concurrently administered a gastric acid-reducing agent, or without regard to whether the patient has an elevated gastric pH. The compositions may be particularly suitable for patients afflicted by achlorhydria or hypochlorhydria, or infection.
Inventor(s):Wertz Christian F., Chen Tzehaw
Assignee:Nanocopoeia, LLC
Application Number:US17206823
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 11,202,778

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of analyzing a U.S. patent, using United States Patent 11,202,778 as an example, and provide a comprehensive guide on how to approach such an analysis.

The Role of the USPTO

The United States Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. Understanding the resources and tools provided by the USPTO is essential for conducting a thorough patent analysis[2].

Tools for Patent Search and Analysis

Patent Public Search

The USPTO offers the Patent Public Search tool, a modern web-based application that replaces legacy search tools. This tool provides enhanced access to prior art and improves the overall patent searching process[1].

Global Dossier

The Global Dossier service allows users to access the file histories of related applications from participating IP Offices, including the IP5 Offices. This service is invaluable for understanding the global patent landscape and identifying office actions and related applications[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs offer training in patent search techniques and maintain local search resources, which can be particularly helpful for those new to patent searching[1].

Understanding Patent Claims

What are Patent Claims?

Patent claims define the scope of the invention and are the legal boundaries of what the patent protects. They are the most critical part of a patent application and must be carefully crafted to ensure the invention is adequately protected[4].

Types of Patent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Method Claims: These claims describe a process or method.
  • Apparatus Claims: These claims describe a device or system[4].

Analyzing the Scope of a Patent

Reading the Patent Specification

The specification of a patent provides a detailed description of the invention, including drawings and examples. It is essential to read the specification to understand the context and limitations of the claims[4].

Claim Construction

Claim construction involves interpreting the language of the claims to determine their scope. This process is critical in patent litigation and can significantly impact the validity and enforceability of the patent[4].

Case Study: United States Patent 11,202,778

To illustrate the process, let's consider a hypothetical analysis of United States Patent 11,202,778, though the specific details of this patent are not provided here.

Step-by-Step Analysis

  1. Identify the Type of Patent: Determine if the patent is a utility, design, or plant patent.
  2. Read the Abstract: The abstract provides a brief summary of the invention.
  3. Review the Claims: Carefully read and analyze each claim to understand the scope of the invention.
  4. Examine the Specification: Read the detailed description of the invention, including any drawings or examples.
  5. Check Prior Art: Use tools like the Patent Public Search or Global Dossier to identify prior art that may affect the patent's validity.
  6. Analyze Office Actions: If available, review office actions to understand any challenges or amendments made during the examination process[1].

Example: Claim Analysis

For instance, if Patent 11,202,778 includes a claim like:

"A method for processing data, comprising: receiving data from a source; analyzing the data using a machine learning algorithm; and generating a report based on the analysis." You would need to identify the key elements (receiving data, analyzing using a machine learning algorithm, generating a report) and determine how these elements are defined and limited within the claim.

Statistical Insights and Trends

Patent Allowance Rates

Studies by the USPTO have shown that the probability of receiving a U.S. patent varies based on several factors, including the technology field and the entity size of the applicant. For example, utility patent applications filed between 1996 and 2005 had different allowance rates depending on whether they were from large or small entities[4].

Patent Scope Measurements

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents and applications, including measures of patent scope. This dataset can help in understanding trends and complexities in patent claims over time[3].

Legal and Policy Considerations

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could simplify and reduce the costs associated with patent litigation for smaller entities. This initiative highlights the ongoing efforts to improve the patent system and make it more accessible[5].

Practical Tips for Conducting a Patent Search

Use Multiple Resources

Utilize the USPTO's Patent Public Search, Global Dossier, and local PTRCs to gather comprehensive information.

Seek Expert Help

Trained staff at the USPTO Public Search Facility or local PTRCs can assist in refining search techniques.

Stay Updated

Regularly check the Official Gazette and other resources for the latest patent issuances and updates[1].

Key Takeaways

  • Understand the Tools: Familiarize yourself with the USPTO's search tools and resources.
  • Analyze Claims Carefully: Claims define the scope of the invention and are critical for patent validity.
  • Consider Prior Art: Prior art can significantly impact the validity of a patent.
  • Stay Informed: Keep up with legal and policy changes that may affect the patent landscape.

FAQs

Q: What is the purpose of the Patent Public Search tool?

A: The Patent Public Search tool is designed to provide enhanced access to prior art and improve the overall patent searching process.

Q: How do I determine the scope of a patent?

A: The scope of a patent is determined by carefully reading and analyzing the claims, as well as understanding the context provided by the specification.

Q: What is the difference between independent and dependent claims?

A: Independent claims stand alone and define the invention without reference to other claims, while dependent claims refer back to and further limit an independent claim.

Q: Where can I find detailed information on patent claims and scope?

A: The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents and applications, including measures of patent scope.

Q: Is there a resource for understanding the global patent landscape?

A: Yes, the Global Dossier service allows users to access the file histories of related applications from participating IP Offices, providing a comprehensive view of the global patent landscape.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Yale Journal of Law & Technology - What Is the Probability of Receiving a US Patent?: https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  5. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,202,778

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Handa Therap PHYRAGO dasatinib TABLET;ORAL 216099-001 Dec 5, 2023 RX Yes No ⤷  Try for Free ⤷  Try for Free USE OF DASATINIB FOR TREATMENT OF ADULTS WITH CHRONIC, ACCELERATED, OR MYELOID OR LYMPHOID BLAST PHASE PH+ CML WITH RESISTANCE OR INTOLERANCE TO PRIOR THERAPY INCLUDING IMATINIB, WHEN COADMINISTERED WITH A GASTRIC ACID REDUCING AGENT ⤷  Try for Free
Handa Therap PHYRAGO dasatinib TABLET;ORAL 216099-001 Dec 5, 2023 RX Yes No ⤷  Try for Free ⤷  Try for Free USE OF DASATINIB FOR TREATMENT OF ADULTS WITH PH+ ALL WITH RESISTANCE OR INTOLERANCE TO PRIOR THERAPY, WHEN COADMINISTERED WITH A GASTRIC ACID REDUCING AGENT ⤷  Try for Free
Handa Therap PHYRAGO dasatinib TABLET;ORAL 216099-001 Dec 5, 2023 RX Yes No ⤷  Try for Free ⤷  Try for Free USE OF DASATINIB FOR TREATMENT OF NEWLY DIAGNOSED ADULTS WITH PH+ CML IN CHRONIC PHASE, WHEN COADMINISTERED WITH A GASTRIC ACID REDUCING AGENT ⤷  Try for Free
Handa Therap PHYRAGO dasatinib TABLET;ORAL 216099-002 Dec 5, 2023 RX Yes No ⤷  Try for Free ⤷  Try for Free USE OF DASATINIB FOR TREATMENT OF ADULTS WITH CHRONIC, ACCELERATED, OR MYELOID OR LYMPHOID BLAST PHASE PH+ CML WITH RESISTANCE OR INTOLERANCE TO PRIOR THERAPY INCLUDING IMATINIB, WHEN COADMINISTERED WITH A GASTRIC ACID REDUCING AGENT ⤷  Try for Free
Handa Therap PHYRAGO dasatinib TABLET;ORAL 216099-002 Dec 5, 2023 RX Yes No ⤷  Try for Free ⤷  Try for Free USE OF DASATINIB FOR TREATMENT OF ADULTS WITH PH+ ALL WITH RESISTANCE OR INTOLERANCE TO PRIOR THERAPY, WHEN COADMINISTERED WITH A GASTRIC ACID REDUCING AGENT ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,202,778

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2021210974 ⤷  Try for Free
Canada 3168667 ⤷  Try for Free
European Patent Office 4093379 ⤷  Try for Free
Israel 294928 ⤷  Try for Free
Japan 2023513444 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.